DMK Pharmaceuticals Other Assets

DMK Pharmaceuticals's other assets stands at $52K as of December 2022. That compares with $110K in the prior-year period — down 52.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

DMK Pharmaceuticals reported $52K in other assets versus $110K a year earlier — a 52.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $110K in the prior-year period — down 52.2% year over year. Sustained growth in other assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how DMK Pharmaceuticals's other assets evolved across reporting periods, while the comparison chart places DMK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other assets is commonly used to spot outliers. DMK Pharmaceuticals's reading of $52K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.